[{"Assets_0_FY_USD":14805200000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":2430000000.0,"NetIncomeLossConverted_1_FY_USD":792000000.0,"NetIncomeLossConverted_4_FY_USD":2115800000.0,"StockholdersEquity_0_FY_USD":11089700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":114600000.0,"EarningsPerShareBasic_1_FY_USD":7.25,"EarningsPerShareBasic_4_FY_USD":19.38,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":109200000.0,"EarningsPerShareDiluted_1_FY_USD":6.93,"EarningsPerShareDiluted_4_FY_USD":18.46,"RevenuesConverted_1_FY_USD":2169500000.0,"RevenuesConverted_4_FY_USD":7863400000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200207"}]